Smith+Nephew SNN recently announced favorable study outcome of a new publication evaluating its PICO Single Use Negative Pressure Wound Therapy System (sNPWT) indicated for use in closed surgical ...
Substantial cost savings with PICO sNPWT SSCs are associated with prolonged hospital stays, increased readmissions, and higher mortality risk, particularly in patients with comorbidities such as ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published comparative study of single-use Negative Pressure Wound Therapy (sNPWT) devices ...
LONDON--(BUSINESS WIRE)--Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health ...
In the study, PICO sNPWT was used immediately post operatively on the closed sternal incision in all CABG procedures. Data was compared with a retrospective cohort of patients where PICO sNPWT had not ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published comparative study of single-use Negative Pressure Wound Therapy (sNPWT) devices ...
"Using PICO sNPWT immediately post operatively was a small change in our clinical practice but we have seen clear benefits for our patients in their recovery" said lead author, Dr Alfred Tabley.
Smith Nephew (NYSE:SNN; LSE:SN), the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback